What were discussing in this issue Will Starbuck
The 2025 ACR data
Therefore, an understanding of the long-term economic value of these medications is necessary for patients, providers, and policymakers, and additional studies are needed to assess their lifetime cost-effectiveness
HERTHENA-Lung01, a phase II trial of patritumab deruxtecan (HER3-DXd) in epidermal growth factor receptor-mutated non-small-cell lung cancer after epidermal growth factor receptor tyrosine kinase inhibitor therapy and platinum-based chemotherapy
Some GLP-1 medications activate a single gut hormone, while others activate multiple hormones for additional effects.We recommend discussing with your Seriously Health provider to determine which GLP-1 medication best fits your individual needs and goals
Saheb Kashaf S, Proctor DM, Deming C, Saary P, Hlzer M, Comparative Sequencing Program NISC et al (2022) Integrating cultivation and metagenomics for a multi-kingdom view of skin microbiome diversity and functions